Express Pharma

Amgen announces positive top-line results from Otezla phase-III Discreet study in moderate-to-severe genital psoriasis

Otezla resulted in clinically and statistically significant improvements in measures of genital psoriasis at week 16 compared with placebo

0 140

Amgen rece